This is associated with demethylation of the Klb promoter and upregulation of its mRNA expression, suggesting that Klb may serve as an epigenetic target that mediates the beneficial effect of Dnmt deficiency on hepatic steatosis. This evidence concerns the gene DNMT1 and fatty liver disease.